Tech Company Financing Transactions
Evogen Funding Round
On 11/17/2008, Evogen secured $3 million in Series B funding from private investors.
Transaction Overview
Company Name
Announced On
11/17/2008
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9393 West 110th St. 500
Overland Park, KS 66210
USA
Overland Park, KS 66210
USA
Phone
Website
Email Address
Overview
Evogen provides air sampling solutions and its technology is used for military, government, and civilian environments in United States.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todd Wallach
VP - Operations
Richard Clair
VP - R & D
John Gledhill
Browse more venture capital transactions:
Prev: 11/17/2008: Zacharon Pharmaceuticals venture capital transaction
Next: 11/17/2008: Eureka Therapeutics venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs